Glanbia plc
GL9
Classement en actions
#3164
Operating globally as a prominent nutrition company, Glanbia plc specializes in... Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
Prix de l'action
$23.02
Capitalisation boursière
$5.56B
Changement (1 jour)
0.00%
Changement (1 an)
33.23%
Pays
IE
Échange Glanbia plc (GL9)
Catégorie
Consumer Defensive
Bénéfices pour Glanbia plc (GL9)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Glanbia plc, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Glanbia plc de 2001 à 2026
Bénéfices à la fin de chaque année
| Année | Bénéfices | Changez |
|---|---|---|
| 2025 | $217.73M | 1.09% |
| 2024 | $215.38M | -44.90% |
| 2023 | $390.89M | 61.74% |
| 2022 | $241.67M | 34.51% |
| 2021 | $179.67M | 12.53% |
| 2020 | $159.66M | -28.53% |
| 2019 | $223.39M | -27.14% |
| 2018 | $306.59M | 11.24% |
| 2017 | $275.62M | 16.58% |
| 2016 | $236.43M | -0.44% |
| 2015 | $237.46M | 13.07% |
| 2014 | $210.02M | -13.23% |
| 2013 | $242.04M | 22.16% |
| 2012 | $198.12M | 44.96% |
| 2011 | $136.67M | -24.12% |
| 2010 | $180.12M | -12.18% |
| 2009 | $205.09M | 41.00% |
| 2008 | $145.45M | 24.74% |
| 2007 | $116.60M | 35.58% |
| 2006 | $86.00M | 12.04% |
| 2005 | $76.76M | -46.99% |
| 2004 | $144.81M | -872.54% |
| 2003 | $-18.74M | 120.20% |
| 2002 | $-8.51M | -117.62% |
| 2001 | $48.30M | 0.00% |
Bénéfices des entreprises similaires ou concurrentes
| Entreprise | Bénéfices | Différence de bénéfices | Pays |
|---|---|---|---|
| $12.96B | - |
CH
|
|
| - | - |
FR
|
|
| - | - |
JP
|
|
| - | - |
BR
|
|
| $-3.66B | - |
US
|
